Command Palette

Search for a command to run...

Clinical Trials · NCT03444142

Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes

UnknownPhase 4Dulaglutide (Unclear)
Phase
Phase 4
Recruitment status
Unknown
Sponsor
University of Guadalajara
Enrollment
30
Start date
Nov 2017
Locations
1 site, Mexico
Primary endpoint
Heart rate: nighttime, daytime and 24-h
View Dulaglutide compound reference